JPRN-UMIN000054037招募中未知
Effects of mobilisation of CD34-positive cells into the peripheral blood after Pegfilgrastim administration and their engraftment on post-transplantation - Effects of mobilisation of CD34-positive cells into the peripheral blood after Pegfilgrastim administration and their engraftment on post-transplantation
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •<Recipient>. 1 Persons who are considered to be at high risk of failure to thrive (as judged by the attending physician). 2 Other persons deemed unsuitable as research subjects by the principal investigator. <Donor 1 Persons who are deemed ineligible during the preoperative medical examination. 2 Other persons deemed unsuitable as research subjects by the principal investigator.
研究者
相似试验
已完成
2 期
Mobilization of CD34+ cells with standard or reduced dose filgrastim after vinorelbine in multiple myeloma patients. A randomized prospecitve single center phase II study.Multiple myelomaC90.0DRKS00003251niversität Zürich60
已完成
1 期
Autologous peripheral blood-derived CD34+ cell transplantation for acute kidney injury.acute kidney injuryJPRN-UMIN000031691Kidney Disease and Transplant Center, Shonan Kamakura General Hospital9
已完成
4 期
Stem Cell Mobilization With Plerixafor in Diabetic vs Control SubjectsDiabetesNCT02056210University of Padova20
已完成
不适用
G-CSF mobilized CD34+ cell transplantation as regenerative medicine for patients with spinal cord injuries.Spinal cord injuryJPRN-UMIN000037388Center for Clinical and Translational Science, Shonan Kamakura General Hospital, Tokushukai Medical Group.6
已完成
不适用
G-CSF mobilized CD34+ cell transplantation as regenerative medicine for patients with critical limb ischemia.Critical limb ischemia in patients undergoing hemodialysisJPRN-UMIN000037339Center for Clinical and Translational Science, Shonan Kamakura General Hospital, Tokushukai Medical Group.1